RVMD in the 13F filings
Revolution Medicines Inc · CUSIP 76155X100
- Quarter end
- 30 Jun 2026
- the date the book describes
- Filed
- 27 Oct 2026
- latest of these filings; the earliest 3 Aug 2026
- Managers listing it
- 31
- at least, of 95 tracked, among listed positions
- Comparable managers
- 91
- filed both Q1 2026 and Q2 2026; 12 listed it in both
- Shares listed
- 56,953,120
- combined, among listed positions
- Reported value
- $10.7bn
- combined, at the quarter end
AllianceBernstein LP. Values in this filing are at the previous quarter end's prices; its share count is the quarter end's.
Among the 91 comparable managers: 16 buyers (opened or added shares) and 23 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was +5,273,867.
Managers listing RVMD in Q2 2026
31 of 31 holders
Largest increases and reductions, by shares
Increases
- Capital World Investorsnew position · 4,008,244 shares now+4,008,244
- Fidelity (FMR LLC)existing position · 12,200,422 shares now+3,736,108
- MFS Investment Managementnew position · 2,012,317 shares now+2,012,317
- AQR Capital Management LLCexisting position · 1,295,450 shares now+1,178,663
- Janus Henderson Group Ltdexisting position · 10,736,145 shares now+969,649
Reductions
- Wellington Management Group LLPexisting position · 3,843,415 shares now-2,184,404
- Holocene Advisors LPexisting position · 1,359,269 shares now-1,109,375
- D. E. Shaw & Co.existing position · 12,400 shares now-1,009,898
- T. Rowe Price Associates Incexisting position · 2,390,303 shares now-841,910
- Two Sigma Investments LPexisting position · 737,697 shares now-821,110
New positions and exits
New (5)
Exited (8)
- Voloridge Investment Management LLCwas $36m
- Squarepoint Ops LLCwas $12m
- Verition Fund Management LLCwas $11m
- Walleye Capital LLCwas $3.1m
- Davidson Kempner Capital Management LPwas $2.6m
- Balyasny Asset Management LLCwas $2.3m
- Winton Group Ltdwas $762k
- Renaissance Technologies LLCwas $603k
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q1 2020 | 4 | $21m | n.a. | n.a. |
| Q2 2020 | 1 | $29m | n.a. | n.a. |
| Q3 2020 | 3 | $388m | n.a. | n.a. |
| Q4 2020 | 4 | $451m | n.a. | n.a. |
| Q1 2021 | 5 | $846m | n.a. | n.a. |
| Q2 2021 | 5 | $325m | n.a. | n.a. |
| Q3 2021 | 3 | $133m | n.a. | n.a. |
| Q4 2021 | 3 | $174m | n.a. | n.a. |
| Q1 2022 | 3 | $174m | n.a. | n.a. |
| Q2 2022 | 3 | $189m | n.a. | n.a. |
| Q3 2022 | 3 | $206m | n.a. | n.a. |
| Q4 2022 | 3 | $263m | n.a. | n.a. |
| Q1 2023 | 5 | $526m | n.a. | n.a. |
| Q2 2023 | 7 | $685m | n.a. | n.a. |
| Q3 2023 | 8 | $766m | n.a. | n.a. |
| Q4 2023 | 8 | $1.0bn | 5 | 3 |
| Q1 2024 | 10 | $1.3bn | 7 | 2 |
| Q2 2024 | 9 | $1.6bn | 4 | 4 |
| Q3 2024 | 10 | $1.9bn | 6 | 3 |
| Q4 2024 | 11 | $2.2bn | 8 | 2 |
| Q1 2025 | 7 | $1.7bn | 5 | 1 |
| Q2 2025 | 8 | $1.7bn | 3 | 4 |
| Q3 2025 | 7 | $2.2bn | 3 | 3 |
| Q4 2025 | 18 | $4.3bn | 23 | 9 |
| Q1 2026 | 15 | $4.8bn | 14 | 20 |
| Q2 2026 | 17 | $10.3bn | 16 | 23 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
RVMD and GILD →RVMD and AMGN →RVMD and ARGX →Choose a stock to compare with RVMD →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own RVMD, latest filings →Back to the 13F Explorer →